Literature DB >> 2052517

Prodrugs of peptides. 9. Bioreversible N-alpha-hydroxyalkylation of the peptide bond to effect protection against carboxypeptidase or other proteolytic enzymes.

H Bundgaard1, G J Rasmussen.   

Abstract

Various N-alpha-hydroxyalkyl derivatives of N-acyl amino acids and di- and tripeptides were prepared by hydrolysis or aminolysis of N-acyl 5-oxazolidinones. The stability of these derivatives was studied in aqueous solution as a function of pH. The compounds were all degraded quantitatively to their parent N-acylated amino acid or peptide and aldehyde but with vastly different rates. At pH 7.4 and 37 degrees C the half-lives of decomposition ranged from 4 min to 1500 hr. The structural factors influencing the stability included both steric and polar effects within the acyl and N-alpha-hydroxyalkyl moieties as well as within the amino acid attached to the N-alpha-hydroxyalkylated N-acyl amino acid. Whereas the N-benzyloxycarbonyl (Z) derivatives of the dipeptides Gly-L-Leu and Gly-L-Ala were readily hydrolyzed by carboxypeptidase A, the N-hydroxymethylated compounds, i.e., Z-Gly(CH2OH)-Leu and Z-Gly(CH2OH)-Ala, were resistant to cleavage by the enzyme as revealed by their similar rates of decomposition in the presence or absence of the enzyme at pH 7.4 and 37 degrees C. The results suggest that N-alpha-hydroxyalkylation of a peptide bond protects not only this bond but also an adjacent peptide bond against proteolytic cleavage. Since the N-alpha-hydroxyalkyl derivatives are readily bioreversible, undergoing spontaneous hydrolysis at physiological pH, this prodrug approach promises to overcome the enzymatic barrier to absorption of various peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052517     DOI: 10.1023/a:1015833229554

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  The specificity of carboxypeptidase.

Authors:  M A STAHMANN; J S FRUTON; M BERGMANN
Journal:  J Biol Chem       Date:  1946-08       Impact factor: 5.157

2.  The application of peptides containing beta-alanine to the study of the specificity of various peptidases.

Authors:  H T HANSON; E L SMITH
Journal:  J Biol Chem       Date:  1948-09       Impact factor: 5.157

3.  The specificity of certain peptidases.

Authors:  E L SMITH
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1951

4.  Structural requirements of specific substrates for carboxypeptidase.

Authors:  J E SNOKE; H NEURATH
Journal:  J Biol Chem       Date:  1949-12       Impact factor: 5.157

5.  Prodrug derivatives of thyrotropin-releasing hormone and other peptides.

Authors:  H Bundgaard; J Møss
Journal:  Biochem Soc Trans       Date:  1989-10       Impact factor: 5.407

6.  Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.

Authors:  S Thaisrivongs; D T Pals; D W Harris; W M Kati; S R Turner
Journal:  J Med Chem       Date:  1986-10       Impact factor: 7.446

Review 7.  Peptides and related drugs: a review of their absorption, metabolism, and excretion.

Authors:  M J Humphrey; P S Ringrose
Journal:  Drug Metab Rev       Date:  1986       Impact factor: 4.518

8.  Synthesis and biological properties of enzyme-resistant analogues of substance P.

Authors:  B E Sandberg; C M Lee; M R Hanley; L L Iversen
Journal:  Eur J Biochem       Date:  1981-02

9.  Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.

Authors:  H Bundgaard; J Møss
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

10.  Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.

Authors:  H Bundgaard; J Møss
Journal:  J Pharm Sci       Date:  1989-02       Impact factor: 3.534

  10 in total
  4 in total

Review 1.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

2.  Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat.

Authors:  P Langguth; G Breves; A Stöckli; H P Merkle; S Wolffram
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

3.  Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.

Authors:  H Bundgaard; G J Rasmussen
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

4.  Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.

Authors:  A H Kahns; H Bundgaard
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.